icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
bWa2kxeuCLxv9Y4p
Listen
